Dangerous Kratom Products Targeting Unsuspecting Consumers

Nonswallowed Kratom-Derived Products: Unlawful Dietary Supplements That Endanger Public Health.

Public health reports (Washington, D.C. : 1974) • • Moderately Relevant
🤖

AI Summary

This research paper reveals a growing public health concern surrounding nontraditional kratom products that deviate from legal dietary supplement guidelines. Researchers uncovered 49 kratom-derived products sold in formats like sublingual strips, buccal pouches, and vaping products, with 67% being vaping formulations. Alarmingly, many of these products contain 7-hydroxymitragynine, an alkaloid that the FDA is seeking to regulate as a controlled substance.

The study highlights significant safety risks, particularly for younger consumers. Most products lacked child-resistant packaging and used marketing strategies that could appeal to children, such as colorful packaging, fruit flavors, and playful mascots. Of particular concern, some kratom vaping products also contained intoxicating hemp cannabinoids, further complicating the potential health risks. The researchers emphasize that these products bypass first-pass metabolism, meaning their absorption and effects are not well understood, which could pose unknown dangers to consumers.

💡 Key Findings

1
67% of kratom products were vaping formulations, with 49 total products identified in nontraditional delivery methods
High
90%
2
Most products lacked child-resistant packaging and used marketing strategies potentially attractive to children
High
85%
3
Some products contained intoxicating hemp cannabinoids alongside 7-hydroxymitragynine
Good
70%

📄 Original Abstract

The Dietary Supplement Health and Education Act of 1994 specified that dietary supplements must be swallowed. In this study, we investigated whether kratom-derived products are being sold to consumers in nonswallowed formulations. Kratom is the fresh or dried leaf powder of the Mitragyna speciosa tree. We identified 49 kratom-derived products being sold in the form of sublingual strips (24%), buccal pouches (8%), and vaping products (67%). Most contained 7-hydroxymitragynine (an alkaloid that the US Food and Drug Administration seeks to make a controlled substance), but we also identified mitragynine extract and mitragynine pseudoindoxyl products. The majority had flavoring or a scent, and some had mascots, pictures of fruit or mint, or formulation colors or packaging that could appeal to children. Most products were not sold in child-resistant packaging. Several kratom vaping products additionally contained intoxicating hemp cannabinoids. With no clinical, safety, or pharmacokinetic data for kratom-derived products that bypass first-pass metabolism (ie, where a chemical absorbed through the stomach or intestines is metabolized in the liver before reaching the general bloodstream), people should be advised to avoid these products, and regulatory action is needed to prevent their sale to consumers.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.